These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 638073)

  • 41. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin-induced and immunologically induced platelet injury.
    Des Prez RM; Bryant RE
    J Exp Med; 1966 Nov; 124(5):971-82. PubMed ID: 5951281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors.
    Niewiarowski S; Kirby EP; Brudzynski TM; Stocker K
    Biochemistry; 1979 Aug; 18(16):3570-7. PubMed ID: 476069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple active forms of thrombin: binding to platelets and effects on platelet function.
    Mohammed SF; Whitworth C; Chuang HY; Lundblad RL; Mason RG
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1660-3. PubMed ID: 1064039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
    Liu D; Zhuang M; Zhang J; Chen J; Sun B
    Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Isolation and function of platelets. I. Platelet rich plasma. Comparison between 2 methods: gel filtration and albumin density gradient centrifugation. II. A new method using total blood: metrizamide gradient centrifugation].
    Lévy-Toledano S; Bredoux R; Rendu F; Jeanneau C; Savariau E; Dassin E
    Nouv Rev Fr Hematol (1978); 1976; 16(3):367-80. PubMed ID: 796828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of bacterial endotoxin and liquoid with blood platelets: aggregation and decrease in the electrokinetic charge.
    Gröttum KA; Hjort PF; Jeremic M
    Thromb Diath Haemorrh; 1969 Aug; 22(1):192-202. PubMed ID: 4980618
    [No Abstract]   [Full Text] [Related]  

  • 51. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of heparin in tumor cell-induced platelet aggregation.
    Yamamoto K; Kitagawa H; Tanoue K; Tsuruo T; Yamamoto N; Yamazaki H
    Thromb Haemost; 1986 Aug; 56(1):90-4. PubMed ID: 3095948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study on rat platelet responsiveness following intravenous endotoxin administration.
    Cicala C; Santacroce C; Itoh H; Douglas GJ; Page CP
    Life Sci; 1997; 60(2):PL31-8. PubMed ID: 9000123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
    Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
    Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Activation of the blood coagulation system during gram-negative infections and endotoxemias].
    Lüscher EF
    Fortschr Med; 1975 Aug; 93(22-23):1072-6. PubMed ID: 1225791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.
    Koessler J; Hermann S; Weber K; Koessler A; Kuhn S; Boeck M; Kobsar A
    PLoS One; 2016; 11(1):e0147370. PubMed ID: 26808867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
    Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement-dependent activation of canine platelets by endotoxin and collagen: in vitro studies.
    Murphy TL; Taylor FB; Welsman IM; Gilliam JM; Taylor FB
    Clin Immunol Immunopathol; 1980 May; 16(1):57-71. PubMed ID: 7379352
    [No Abstract]   [Full Text] [Related]  

  • 60. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG; Frojmovic MM; Tang SS; White JG
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.